Clinical trial
Phase 3 Study of Effect of ATorvastatin on Fractional Flow Reserve in Coronary Artery Disease
NCT01946815 is registered in ClinicalTrials.gov with Keimyung University Dongsan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3 Study of Effect of ATorvastatin on Fractional Flow Reserve in Coronary Artery Disease
- Lead sponsor
- Keimyung University Dongsan Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- November 30, 2018
- Enrollment
- 119 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.